Chroma's MagXtract® 3200 has been approved by CE-IVD, FDA and TFDA. It’s a compact bench-top system achieves fully automated nucleic acid extraction and PCR setup that brings you walkaway automation, designed to eliminate virtually all manual steps with automation, consolidation, integration and standardization, which allows clinicians, researchers or technicians to focus on more sophisticated activities.
Receipt of the regulatory approval from competent authority is an important step forward on our path to commercialize MagXtract® 3200's innovative and efficient, yet simple-to-use molecular diagnostic technology.The CE Mark, FDA and TFDA approval allow Chroma to market and sell the MagXtract® 3200 in Europe, the U.S and Taiwan, as well as other countries that accept these certifications.
Chroma is going to expand our first own-brand molecular diagnostic instrument to international customers. Welcome become our distribution and business partners, do not hesitate to contact us, we will have designated person to reply to you soon.
Contact us
E: info@chromaate.com
T: +886 (03) 327-9999